Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
01-02 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
01-02 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
10 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250610559917/en/Mirum-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
19 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250519899640/en/Mirum-Pharmaceuticals-Appoints-Doug-Sheehy-JD-as-Chief-Legal-Officer
14 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250514147482/en/Mirum-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences
09 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250509189818/en/Volixibat-Data-from-Mirums-VANTAGE-PBC-Study-Showcased-at-EASL
09 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250509671797/en/Mirum-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507261079/en/Mirum-Pharmaceuticals-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : CTEXLI
Dosage Strength : 250MG
Packaging :
Approval Date : 2025-02-21
Application Number : 219488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : CHOLBAM
Dosage Strength : 50MG
Packaging :
Approval Date : 2015-03-17
Application Number : 205750
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : CHOLBAM
Dosage Strength : 250MG
Packaging :
Approval Date : 2015-03-17
Application Number : 205750
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;ORAL
Brand Name : LIVMARLI
Dosage Strength : EQ 9.5MG BASE/ML
Packaging :
Approval Date : 2021-09-29
Application Number : 214662
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : LIVMARLI
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2025-04-10
Application Number : 219485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : LIVMARLI
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2025-04-10
Application Number : 219485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;ORAL
Brand Name : LIVMARLI
Dosage Strength : EQ 19MG BASE/ML
Packaging :
Approval Date : 2024-07-24
Application Number : 214662
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : LIVMARLI
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2025-04-10
Application Number : 219485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : LIVMARLI
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2025-04-10
Application Number : 219485
Regulatory Info : RX
Registration Country : USA
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : CTEXLI
Dosage Strength : 250MG
Approval Date : 2025-02-21
Application Number : 219488
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : CHOLBAM
Dosage Strength : 50MG
Approval Date : 2015-03-17
Application Number : 205750
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : CHOLBAM
Dosage Strength : 250MG
Approval Date : 2015-03-17
Application Number : 205750
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION; ORAL
Proprietary Name : LIVMARLI
Dosage Strength : EQ 9.5MG BASE/ML
Approval Date : 2021-09-29
Application Number : 214662
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION; ORAL
Proprietary Name : LIVMARLI
Dosage Strength : EQ 19MG BASE/ML
Approval Date : 2024-07-24
Application Number : 214662
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : LIVMARLI
Dosage Strength : EQ 10MG BASE
Approval Date : 2025-04-10
Application Number : 219485
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : LIVMARLI
Dosage Strength : EQ 15MG BASE
Approval Date : 2025-04-10
Application Number : 219485
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : LIVMARLI
Dosage Strength : EQ 20MG BASE
Approval Date : 2025-04-10
Application Number : 219485
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : LIVMARLI
Dosage Strength : EQ 30MG BASE
Approval Date : 2025-04-10
Application Number : 219485
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
ABOUT THIS PAGE